LISI Group confirms the sale of its LISI MEDICAL division to SK CAPITAL

Further to the press release dated October 23, LISI Group confirms the sale of its LISI MEDICAL division to SK CAPITAL, a private American investor, on October 31, 2025. LISI MEDICAL has been renamed Precera Medical and has established its headquarters in Minneapolis (United States).

At the same time, LISI Group becomes a partner in Precera Medical's development strategy by acquiring a minority stake of 9.988% in the holding company comprising the entire acquisition by SK CAPITAL, thereby joining the planned development project and the emergence of Precera Medical as a leading CDMO* partner for equipment manufacturers.

In addition, LISI Group will be able to benefit from an additional payment depending on the terms of SK CAPITAL's exit at the end of its investment.

"This transaction marks the end of an important chapter for LISI Group and the beginning of an exciting new adventure for Precera Medical. I am proud of the growth we have achieved since the division was created in 2010. The long-term foundation we invested in, combined with SK CAPITAL's industrial and financial resources, will enable Precera Medical and its teams to thrive as an independent company supporting the growth of its customers," said Emmanuel Viellard, CEO of LISI Group.